APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Frovatriptan Succinate Tablets

Frovatriptan Succinate Tablets are immediate-release, film-coated oral tablets containing frovatriptan as the succinate monohydrate salt for the acute treatment of migraine with or without aura in adults; they are not intended for prophylaxis. The clinical strength is standardized to 2.5 mg frovatriptan free base per tablet, achieved by 3.91 mg frovatriptan succinate (monohydrate) as the active pharmaceutical ingredient (API). The succinate salt is selected for robust…

Types
Originator (RMP) · Originator-Licensed Brand · Authorized Generic (AG)
Applications
Hospital and Clinic · Retail Pharmacies · Other

5 editions21 December 2025

View 5 research editions
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: Amifostine HydrateCompare research options for Amifostine Hydrate
APO Research, Inc.